Price
CHART BY
Frequently asked questions
What is Caris Life Sciences, Inc.'s market capitalization?
The market capitalization of Caris Life Sciences, Inc. is $6.88B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Caris Life Sciences, Inc.'s Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Caris Life Sciences, Inc. is 65.38. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Caris Life Sciences, Inc.?
Caris Life Sciences, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.372. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Caris Life Sciences, Inc.'s stock?
Currently, 14 analysts cover Caris Life Sciences, Inc.'s stock, with a consensus target price of $27.38. Analyst ratings provide insights into the stock's expected performance.
What is Caris Life Sciences, Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, Caris Life Sciences, Inc. reported a revenue of $989.61M.
What is the EBITDA for Caris Life Sciences, Inc.?
Caris Life Sciences, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $174.02M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Caris Life Sciences, Inc.?
Caris Life Sciences, Inc. has a free cash flow of $116.25M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Caris Life Sciences, Inc. have, and what sector and industry does it belong to?
Caris Life Sciences, Inc. employs approximately 1,846 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Caris Life Sciences, Inc.'s shares?
The free float of Caris Life Sciences, Inc. is 126.33M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $6.88B
- EPS (TTM)
- $0.372
- Free Float
- 126.33M
- P/E ratio (TTM)
- 65.38
- Revenue (TTM)
- $989.61M
- EBITDA (TTM)
- $174.02M
- Free Cashflow (TTM)
- $116.25M
Pricing
- 1D span
- $24.00$24.72
- 52W span
- $14.19$34.35
Analyst Ratings
The price target is $27.38 and the stock is covered by 14 analysts.
Buy
10
Hold
4
Sell
0
Information
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.
- Employees
- 1,846
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- CAI
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet